US Makes First Reformulated Ranitidine Approval Since Withdrawal, Starting With Rx Tablets

 
• By Malcolm Spicer
  
VKT Pharma has received FDA approval for 150- and 300-mg tablets of histamine H2-blocker ranitidine tablets. (Shutterstock)
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business